|
Study group
|
Study population (N)
|
Overall Bartonella spp prevalence N (%)
|
BAPGM diagnostic platform
|
Overall molecular prevalence of other CVBD pathogens N (%)
|
Hemotropic Mycoplasma 16S PCR
|
Ehrlichia/Anaplasma spp PCR
|
SFG Rickettsia PCR
|
Babesia spp PCR
|
|---|
| | | |
Pre-enrichment PCR
|
Post-enrichment PCR
|
Isolate
| | | | | |
|---|
|
Group I
|
47
|
9 (19%)
|
Bk
(3)
|
Bh SA2 (2)
|
0
|
3 (6%)
|
Mhc
(3)
|
0
|
0
|
0
|
|
Bh HI (1)
|
B spp. (2)
|
|
B spp. (1)
|
|
Group II
|
50
|
10 (20%)
|
Bvb III (1)
|
Bvb II (1)
|
Bvb II (8)
|
3 (6%)
|
Mhc
(1)
|
E. ewingii
(2)
|
0
|
0
|
|
Group III
|
21
|
2 (10%)
|
Bvb I (1)†
|
Bvb I (1)*
|
Bvb I (1)*
|
4 (19%)
|
Mhc
(1)
|
E. ewingii
(2)
|
0
|
0
|
| | | |
Bvb I (1)*
| | | |
C Mhp
(1)
| | | |
- Legend: Bk – Bartonella koehlerae; Bh SA2 – Bartonella henselae San Antonio 2; Bh HI– Bartonella henselae Houston 1; Bvb – Bartonella vinsonii subsp berkhoffii genotypes I, II, & III; CVBD – Canine vector borne disease; † - Bvb genotype I DNA sequence amplified from serum; * - Bvb genotype I DNA sequence amplified from blood; Mhc – Mycoplasma hemocanis; C Mhp- Candidatus M. hematoparvum; B spp – Bartonella spp; BAPGM – Bartonella Alpha Proteobacteria Growth Medium; PCR – Polymerase chain reaction; SFG – Spotted fever group.
